Petter Bjerke
PARTNER, LOCATION HEAD IPT Petter Bjerke, heads DLA Piper Norway’s Intellectual Property and Technology (IPT) department and regularly assists Norwegian and multinational companies in manufacturing, pharmaceutical, media and finance with issues related to data privacy (GDPR) and cyber security as well as intellectual property rights. He has served as Data Protection Officer for a global life science company. He also advises clients within the life science sector (service providers, manufactures of medical devices and pharmaceuticals) on sector specific regulatory issues in connection with various research programs, standard operation procedures, clinical trials, commercialization and distribution / procurement projects as well as …
PARTNER, LOCATION HEAD IPT
Petter Bjerke, heads DLA Piper Norway’s Intellectual Property and Technology (IPT) department and regularly assists Norwegian and multinational companies in manufacturing, pharmaceutical, media and finance with issues related to data privacy (GDPR) and cyber security as well as intellectual property rights. He has served as Data Protection Officer for a global life science company. He also advises clients within the life science sector (service providers, manufactures of medical devices and pharmaceuticals) on sector specific regulatory issues in connection with various research programs, standard operation procedures, clinical trials, commercialization and distribution / procurement projects as well as obligations imposed though various codes of conduct applicable to the life science sector.
See more
Petter Bjerke, heads DLA Piper Norway’s Intellectual Property and Technology (IPT) department and regularly assists Norwegian and multinational companies in manufacturing, pharmaceutical, media and finance with issues related to data privacy (GDPR) and cyber security as well as intellectual property rights. He has served as Data Protection Officer for a global life science company. He also advises clients within the life science sector (service providers, manufactures of medical devices and pharmaceuticals) on sector specific regulatory issues in connection with various research programs, standard operation procedures, clinical trials, commercialization and distribution / procurement projects as well as obligations imposed though various codes of conduct applicable to the life science sector.
